TScan Therapeutics (TCRX) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for TScan Therapeutics (TCRX) over the last 5 years, with Q3 2025 value amounting to 0.03.
- TScan Therapeutics' Asset Utilization Ratio rose 1597.86% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year increase of 1597.86%. This contributed to the annual value of 0.01 for FY2024, which is 9019.94% down from last year.
- As of Q3 2025, TScan Therapeutics' Asset Utilization Ratio stood at 0.03, which was up 1597.86% from 0.02 recorded in Q2 2025.
- Over the past 5 years, TScan Therapeutics' Asset Utilization Ratio peaked at 0.09 during Q1 2023, and registered a low of 0.01 during Q4 2024.
- Its 5-year average for Asset Utilization Ratio is 0.05, with a median of 0.05 in 2023.
- Per our database at Business Quant, TScan Therapeutics' Asset Utilization Ratio soared by 7330.0% in 2022 and then plummeted by 8899.21% in 2024.
- Quarter analysis of 5 years shows TScan Therapeutics' Asset Utilization Ratio stood at 0.05 in 2021, then surged by 43.88% to 0.07 in 2022, then decreased by 4.19% to 0.07 in 2023, then tumbled by 88.99% to 0.01 in 2024, then surged by 283.58% to 0.03 in 2025.
- Its Asset Utilization Ratio was 0.03 in Q3 2025, compared to 0.02 in Q2 2025 and 0.01 in Q1 2025.